BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17961256)

  • 1. Impact of prescription size on statin adherence and cholesterol levels.
    Batal HA; Krantz MJ; Dale RA; Mehler PS; Steiner JF
    BMC Health Serv Res; 2007 Oct; 7():175. PubMed ID: 17961256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of copayment with likelihood and level of adherence in new users of statins: a retrospective cohort study.
    Watanabe JH; Kazerooni R; Bounthavong M
    J Manag Care Pharm; 2014 Jan; 20(1):43-50. PubMed ID: 24372459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of concurrent medication use on statin adherence and refill persistence.
    Grant RW; O'Leary KM; Weilburg JB; Singer DE; Meigs JB
    Arch Intern Med; 2004 Nov; 164(21):2343-8. PubMed ID: 15557413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between statin adherence level, health care costs, and utilization.
    Zhao Y; Zabriski S; Bertram C
    J Manag Care Spec Pharm; 2014 Jul; 20(7):703-13. PubMed ID: 24967523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of factors associated with statin adherence in a hierarchical model considering physician, pharmacy, patient, and prescription characteristics.
    Pedan A; Varasteh L; Schneeweiss S
    J Manag Care Pharm; 2007; 13(6):487-96. PubMed ID: 17672810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication adherence trends with statins.
    Huser MA; Evans TS; Berger V
    Adv Ther; 2005; 22(2):163-71. PubMed ID: 16020406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
    Blackburn DF; Dobson RT; Blackburn JL; Wilson TW; Stang MR; Semchuk WM
    Can J Cardiol; 2005 May; 21(6):485-8. PubMed ID: 15917876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Associated With Adherence to Statin Medications of Patients Enrolled in a Self-insured University Health Plan.
    Range JT; LaFontaine PR; Ryder PT; Polston M
    Clin Ther; 2018 Oct; 40(10):1692-1700. PubMed ID: 30231972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between statin adherence and cholesterol level reduction from baseline in a veteran population.
    Kazerooni R; Watanabe JH; Bounthavong M
    Pharmacotherapy; 2013 Oct; 33(10):1044-52. PubMed ID: 23744794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting 1-Year Statin Adherence Among Prevalent Users: A Retrospective Cohort Study.
    Krumme AA; Franklin JM; Isaman DL; Matlin OS; Tong AY; Spettell CM; Brennan TA; Shrank WH; Choudhry NK
    J Manag Care Spec Pharm; 2017 Apr; 23(4):494-502. PubMed ID: 28345442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a pharmacist-driven medication adherence enhancement service.
    Rinehart SN; Collins C; Glover J; Rice WM
    J Manag Care Spec Pharm; 2021 Apr; 27(4):507-515. PubMed ID: 33769859
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical utilization and costs associated with statin adherence in Medicaid enrollees with type 2 diabetes.
    Wu J; Seiber E; Lacombe VA; Nahata MC; Balkrishnan R
    Ann Pharmacother; 2011 Mar; 45(3):342-9. PubMed ID: 21325098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary nonadherence to statin medications in a managed care organization.
    Cheetham TC; Niu F; Green K; Scott RD; Derose SF; Vansomphone SS; Shin J; Tunceli K; Reynolds K
    J Manag Care Pharm; 2013 Jun; 19(5):367-73. PubMed ID: 23697474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study.
    Ye X; Gross CR; Schommer J; Cline R; St Peter WL
    Clin Ther; 2007 Dec; 29(12):2748-57. PubMed ID: 18201593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin Adherence Rates in Patients Utilizing a Patient-Centered Medical Home-Based Pharmacy.
    Slazak EM; Kozakiewicz JT; Winters NS; Smith JR; Monte SV
    J Pharm Pract; 2017 Oct; 30(5):516-520. PubMed ID: 27599748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy.
    Benner JS; Tierce JC; Ballantyne CM; Prasad C; Bullano MF; Willey VJ; Erbey J; Sugano DS
    Pharmacoeconomics; 2004; 22 Suppl 3():13-23. PubMed ID: 15669150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to statins and LDL-cholesterol goal attainment.
    Chi MD; Vansomphone SS; Liu IL; Cheetham C; Green KR; Scott RD; Reynolds K
    Am J Manag Care; 2014 Apr; 20(4):e105-12. PubMed ID: 24884955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with healthcare utilization costs for statin therapy--a pilot study in Hong Kong.
    Cheng CW; Chan JC; Tomlinson B; Woo KS; You JH
    Int J Clin Pharmacol Ther; 2006 Oct; 44(10):484-8. PubMed ID: 17063979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipid-lowering therapy and patient adherence in the MULTI GAP 2013 trial].
    Simonyi G
    Orv Hetil; 2014 Apr; 155(17):669-75. PubMed ID: 24755449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use.
    Brookhart MA; Patrick AR; Schneeweiss S; Avorn J; Dormuth C; Shrank W; van Wijk BL; Cadarette SM; Canning CF; Solomon DH
    Arch Intern Med; 2007 Apr; 167(8):847-52. PubMed ID: 17452550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.